Qualitative or quantitative defects of protein ZASP

Qualitative or quantitative defects of ZASP (Z-band alternatively spliced PDZ-motif protein, also known as LDB3 or cypher) refer to a group of rare genetic conditions caused by mutations in the LDB3 gene (also called ZASP or LIM domain-binding 3). ZASP is a critical structural protein found in the Z-disc of striated muscle, where it plays an essential role in maintaining the structural integrity of the sarcomere during muscle contraction. Defects in this protein primarily affect skeletal and cardiac muscle, leading to myofibrillar myopathy (specifically myofibrillar myopathy type 4, also known as zaspopathy) and/or dilated cardiomyopathy. Clinical manifestations typically include progressive skeletal muscle weakness, which often begins in the distal muscles of the lower limbs (particularly the anterior compartment) and may later involve proximal muscles. Cardiac involvement can include dilated cardiomyopathy or left ventricular noncompaction, which may lead to heart failure and arrhythmias. Muscle biopsy characteristically shows myofibrillar disorganization with accumulation of desmin and other Z-disc proteins. Onset is usually in adulthood, though variability exists depending on the specific mutation. There is currently no curative treatment for ZASP-related disorders. Management is supportive and multidisciplinary, including physical therapy to maintain mobility, cardiac monitoring and treatment of cardiomyopathy with standard heart failure medications, and respiratory support if needed. Genetic counseling is recommended for affected individuals and their families. Regular cardiac surveillance is important even in patients presenting primarily with skeletal myopathy, as cardiac involvement may develop over time.

Common questions about Qualitative or quantitative defects of protein ZASP